ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

AstraZeneca virus vaccine shows promise in trial

UK company expects to begin Japan tests in August

Some of the many vaccines being rushed through development are starting to show promise.   © Reuters

LONDON/TOKYO -- A coronavirus vaccine being developed by British pharmaceutical AstraZeneca and Oxford University showed a robust immune response in the early phases of its trial.

The company is expected to begin trials in Japan in August as the world waits for a vaccine to stop the pandemic.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more